Shandong Fengyuan Chemical (002805.SZ) expects a pre-loss, with an estimated net loss of 230 million to 330 million yuan for the year 2024.
Fengyuan Group (002805.SZ) released its performance forecast for the year 2024, expecting a full-year attributable to shareholders of the listed company...
Shandong Fengyuan Chemical (002805.SZ) released its performance forecast for the year 2024, expecting a net loss of 230 million to 330 million yuan attributable to shareholders of the listed company for the full year. During the reporting period, the company actively took various measures to reduce costs, increase efficiency, continuously improve product quality, enrich product structure, and enhance competitiveness. Due to the impact of changes in the industry supply and demand landscape, although the sales volume of the company's lithium battery cathode materials products has significantly increased compared to the previous year, the product prices have decreased year-on-year. In addition, the overall equipment utilization rate is insufficient, resulting in higher manufacturing costs per unit of finished product, coupled with inventory markdown losses, asset impairments, and credit impairments, these factors collectively led to the company's performance losses.
Related Articles

Capitalonline Data Service(300846.SZ): Tianyang Hongye intends to acquire 5.02% of the company's shares.

Chongqing Qin'an M&E PLC (603758.SH) intends to purchase a 99% stake in Yeguang Electronics in cash.

S.F. Holding (06936) controlling shareholder Mingde Holdings has transferred its holdings of 200 million A shares to the securities account of the employee stock ownership plan (A shares).
Capitalonline Data Service(300846.SZ): Tianyang Hongye intends to acquire 5.02% of the company's shares.

Chongqing Qin'an M&E PLC (603758.SH) intends to purchase a 99% stake in Yeguang Electronics in cash.

S.F. Holding (06936) controlling shareholder Mingde Holdings has transferred its holdings of 200 million A shares to the securities account of the employee stock ownership plan (A shares).

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025